Soporific :: Consumers survey results of for 2 quarter of 2024

Consumers survey results of for 2 quarter of 2024 in category

Sedatives, soporifics / Soporific

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)

1.	Донорміл (Bristol-Myers Squibb)	50.00%	5

2.	Barbovalum (Farmak)	25.00%	2.50

2.	Віта-мелатонін (Київський вітамінний завод)	25.00%	2.50

2.	Депривіт (Київський вітамінний завод)	25.00%	2.50

2.	Сон-норма (Національна гомеопатична спілка)	25.00%	2.50

–.	Persen Night (Alvogen Ukraine)	0.00%	0

–.	Антістрес-Лабофарм (Unipharma)	0.00%	0

–.	Дорміплант (Schwabe)	0.00%	0

–.	Ліксон (ОЗ «ГНЦЛС»)	0.00%	0

–.	Сондокс (Red star)	0.00%	0

–.	Сонміл (Київський вітамінний завод)	0.00%	0

–.	Соннікс (Астрафарм)	0.00%	0

–.	Тривалумен (Борщагівський ХФЗ)	0.00%	0

–.	Трипсидан (Surya Herbal Limited)	0.00%	0

This rating reflects the current interim results of the study of public opinion as on 8/24/2024 16:16:31 and it’s not yet final.

Strictly prohibited any use and reproduction of unfinished voting results without link to the source, without clear explanation of the methodology of the “Favorites of Success” Contest and without mandatory notes that poll is still continues and this result is not yet final.